Tier 2 · Liquid 3000

Taysha Gene Therapies, Inc.

TSHA · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$5.60
+0.00%
Coverage
Tier 2
Tier 2 · Liquid 3000
SEC CIK
0001806310
Liquidity rank
#2334
Observed dollar volume

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$9.77M2025-12-310001193125-26-115202
Annual diluted EPS-0.342025-12-310001193125-26-115202
Quarterly revenue$0.002026-06-300001193125-26-344610
Quarterly diluted EPS-0.132026-06-300001193125-26-344610

SEC EDGAR Frames batch generated 2026-09-08T00:39:23.556Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Dividends

Trailing 12 months
Not published
Latest payment
Not published

Yahoo Finance corporate actions. Window: 2025-09-21 through 2026-09-21.

Seasonality

MonthMean returnPositiven

Monthly close-to-close returns, trailing 15 years where Yahoo history is available.

Sector news

Amulet Capital Promotes Sam Brinkley To Partner As Healthcare Private Equity Firm Expands Fertility Investment Strategy - Pulse 2.0Pulse 2.0 · 2026-09-20
Advanced diagnostic imaging: the investment case moves beyond consolidation - Investors in HealthcareInvestors in Healthcare · 2026-09-21
Hecto Healthcare buys stake in supplement maker Novawells as revenue nears $73M - DealroomDealroom · 2026-09-20
rest-of-south-america Smart Hospital Market Size, Share,Trends, Growth Analysis Report, 2031 - marketsandmarkets.commarketsandmarkets.com · 2026-09-20
Weekly Market Update: Stocks Flat as Healthcare Rises, Utilities Fall - MorningstarMorningstar · 2026-09-18

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerMRK · Tier 1 peerPFE · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames